Special Issue "HPV Associated Cancers"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 May 2016).
Interests: HPV in cervical cancer; screening; vaccination; biomolecular study in gynecological cancer; gestational trophoblastic diseases; treatment of gynecological cancers
Human Papillomavirus (HPV) is the major cause of cervical cancer. HPV is also associated with other anogenital tract cancers such as vaginal, vulval, peneal and anal cancers. HPV is also found in esophageal cancer and nasopharyngeal cancers. Our understanding of HPV led to the development of HPV testing in cervical cancer screening and HPV vaccination in prevention of anogenital cancers. What is lacking is a cost-effective protocol on the use of HPV testing and how to overcome obstacles in the implementation of HPV vaccination worldwide.
In our understanding of HPV and cancer, there is still a gap on how HPV develops to cancer only in a minority of infections while the majority remain clear. Therapeutic HPV vaccines are promising but lack robust clinical studies to support their use. Understanding how HPV related pathways lead to carcinogenesis may help in developing new targets for treating cervical cancer.
This Special Issue will highlight the role of HPV in different cancers, its clinical application and strategy in prevention and control of cancers. A more basic study on HPV related molecular pathways will advance our understanding of HPV carcinogenesis and help in developing new targets in the prevention and therapy of HPV associated cancer.
Prof. Hextan Y.S. Ngan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cervical Cancer
- Anogenital Cancer
- Head and neck cancer
- Esophageal cancer
- Cancer prevention
- Cancer vaccination
- Targeted therapy
- Cancer stem cells
- Molecular study